Log in
Enquire now

List of Cumberland Pharmaceuticals patents

List of Cumberland Pharmaceuticals patents
List of Jarden Zinc Products patents
List of Syqe patents
List of Innovative Solutions & Support (company) patents
List of funding rounds for LevelTen Energy
List of AI webcam companies
Patents where
Current Assignee
Name
is
Cumberland PharmaceuticalsCumberland Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8653061 Acetylcysteine composition and uses thereof

Patent 8653061 was granted and assigned to Cumberland Pharmaceuticals on February, 2014 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8653061
February 18, 2014
‌
US Patent 8952065 Acetylcysteine composition and uses thereof

Patent 8952065 was granted and assigned to Cumberland Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8952065
February 10, 2015
‌
US Patent 8148356 Acetylcysteine composition and uses therefor

Patent 8148356 was granted and assigned to Cumberland Pharmaceuticals on April, 2012 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8148356
April 3, 2012
‌
US Patent 8399445 Acetylcysteine composition and uses thereof

Patent 8399445 was granted and assigned to Cumberland Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8399445
March 19, 2013
‌
US Patent 9114068 Treating patients with intravenous ibuprofen

Patent 9114068 was granted and assigned to Cumberland Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9114068
August 25, 2015
‌
US Patent 9327028 Acetylcysteine compositions and methods of use thereof

Patent 9327028 was granted and assigned to Cumberland Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9327028
May 3, 2016
‌
US Patent 8722738 Acetycysteine compositions and methods of use thereof

Patent 8722738 was granted and assigned to Cumberland Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8722738
May 13, 2014
‌
US Patent 9649284 Treating critically ill patients with intravenous ibuprofen

Patent 9649284 was granted and assigned to Cumberland Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9649284
May 16, 2017
‌
US Patent 9072661 Injectable ibuprofen formulation

Patent 9072661 was granted and assigned to Cumberland Pharmaceuticals on July, 2015 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9072661
July 7, 2015
‌
US Patent 9931311 Treating critically ill patients with intravenous ibuprofen

Patent 9931311 was granted and assigned to Cumberland Pharmaceuticals on April, 2018 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9931311
April 3, 2018
‌
US Patent 9072710 Injectable ibuprofen formulation

Patent 9072710 was granted and assigned to Cumberland Pharmaceuticals on July, 2015 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9072710
July 7, 2015
‌
US Patent 9295639 Treating critically ill patients with intravenous ibuprofen

Patent 9295639 was granted and assigned to Cumberland Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9295639
March 29, 2016
‌
US Patent 9138404 Treating critically ill patients with intravenous ibuprofen

Patent 9138404 was granted and assigned to Cumberland Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9138404
September 22, 2015
‌
US Patent 8933115 Stabilized statin formulations

Patent 8933115 was granted and assigned to Cumberland Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8933115
January 13, 2015
‌
US Patent 8871810 Treating critically ill patients with intravenous ibuprofen

Patent 8871810 was granted and assigned to Cumberland Pharmaceuticals on October, 2014 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8871810
October 28, 2014
‌
US Patent 10751383 Doses and methods for administering telavancin

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10751383
August 25, 2020
‌
US Patent 8735452 Treating patients with intravenous ibuprofen

Patent 8735452 was granted and assigned to Cumberland Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8735452
May 27, 2014
‌
US Patent 11571412 Thromboxane receptor antagonists in AERD/asthma

Patent 11571412 was granted and assigned to Cumberland Pharmaceuticals on February, 2023 by the United States Patent and Trademark Office.

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
Cumberland Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11571412
February 7, 2023
18 results
0 selected
18 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us